Today: 8 June 2026
Analog Devices stock drifts into year-end as Fed minutes loom
29 December 2025
2 mins read

Analog Devices stock drifts into year-end as Fed minutes loom

NEW YORK, December 29, 2025, 00:40 ET — Market closed

  • Analog Devices ended the last session down 0.3% at $276.84, lagging a mixed chip sector.
  • Investors head into the final week of 2025 focused on the Federal Reserve’s meeting minutes due Tuesday.
  • Fresh reads on chip demand, including South Korea’s December trade report on Jan. 1, are in focus.

Analog Devices shares closed down 0.3% at $276.84 in the most recent session, as investors headed into a holiday-shortened week with the Federal Reserve’s December meeting minutes due Tuesday.

The stock’s positioning matters now because year-end trading volumes are typically thin, and macro headlines can move rate expectations quickly. Chipmakers, including analog chip firms, often trade with shifts in borrowing-cost assumptions because investors treat them as sensitive to the economic cycle.

Minutes from the Fed’s last policy meeting — the detailed account of the discussions behind its rate decision — are due Tuesday, with markets watching for clues on how soon officials may ease again. Reuters reported traders have been pricing in more rate cuts in 2026 than the Fed’s latest projections implied.

Within semiconductors, exchange-traded funds were mixed at the last close, with the VanEck Semiconductor ETF up 0.5% while the iShares Semiconductor ETF was little changed. Texas Instruments slipped 0.1% and Microchip Technology fell 0.7% in the same session.

Analog Devices makes analog and mixed-signal chips used in applications such as industrial equipment, communications systems and other electronics, which can make demand sensitive to shifts in capital spending.

“Markets will scour the minutes for deeper insights into the committee debates on the balance of risks and the timing of future easing,” Tony Sycamore, market analyst at IG, said. Reuters

Investors are also watching global signals on semiconductor demand after a Reuters poll showed South Korean exports were expected to rise 9% year-on-year in December, led by chips tied to artificial intelligence-related demand. South Korea is scheduled to report the trade figures on Jan. 1.

For Analog Devices, the latest major company catalyst remains its late-November results and outlook, when the company forecast first-quarter revenue and profit above analysts’ estimates on resilient demand and said it was seeing strength in bookings.

The next scheduled catalyst for the company is its upcoming earnings report, though the firm has not confirmed a date. Nasdaq and Zacks list Feb. 18, 2026 as an estimate for the next report.

Before the next session, traders will key on U.S. economic data due Monday and Tuesday and how it shapes expectations for interest rates and growth. A Barron’s preview flagged pending home sales on Monday and the Fed minutes on Tuesday among the events on the docket.

Investors will also navigate another holiday week, with U.S. markets set to close for New Year’s Day. Low liquidity around holidays can amplify moves in heavily traded sectors such as technology and semiconductors.

On the technical side, Analog Devices traded between $275.96 and $278.50 in the latest session, leaving the stock hovering near the middle of its recent range going into Monday’s open.

Beyond the macro calendar, chip investors will be watching for any new signals on factory and automotive demand — key end-markets for analog chips — alongside broader sentiment around AI-linked spending, which has supported technology shares.

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Copper spikes near $13,000 a ton as London catches up after holiday, tariff fears bite
Next Story

Copper spikes near $13,000 a ton as London catches up after holiday, tariff fears bite

Go toTop